StockNews.AI
ELV
StockNews.AI
35 days

ELEVANCE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Elevance Health, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

1. Bragar Eagel & Squire investigates claims against Elevance Health, Inc. 2. Class action filed due to misleading statements regarding Medicaid costs. 3. Elevance allegedly misrepresented its financial guidance related to Medicaid redetermination. 4. Long-term stockholders encouraged to discuss legal options for losses. 5. Investors may have suffered damages from undisclosed financial risks.

5m saved
Insight
Article

FAQ

Why Very Bearish?

The legal investigation suggests significant fiduciary breaches, potentially leading to stock declines. In similar cases, stock prices for companies facing lawsuits often suffer short-term declines as investor confidence wanes.

How important is it?

The potential impact on Elevance's stock and investor sentiment is significant. A class action lawsuit can lead to severe legal and financial consequences, indicating a high likelihood of impacting stock price.

Why Short Term?

Any immediate fallout from legal issues tends to impact prices rapidly. High-profile lawsuits frequently lead to quick market reactions as investors reassess risk.

Related Companies

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Elevance (ELV) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in Elevance between April 18, 2024, and October 16, 2024 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Elevance Health, Inc. (NYSE:ELV) on behalf of long-term stockholders following a class action complaint that was filed against Elevance on May 12, 2025 with a Class Period from April 18, 2024, and October 16, 2024. Our investigation concerns whether the board of directors of Elevance have breached their fiduciary duties to the company. According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that, with the Medicaid redetermination process nearly complete, defendants represented to investors that they were closely monitoring cost trends associated with the redetermination process and that the premium rates Elevance was negotiating with states were sufficient to address the risk and cost profiles of those patients staying on Medicaid programs. While defendants acknowledged that Medicaid expenses were rising, they repeatedly assured investors that this was adequately reflected in Elevance’s guidance for the year. These representations were materially false or misleading. In truth, the redeterminations were causing the acuity and utilization of Elevance’s Medicaid members to rise significantly, as the members being removed from Medicaid programs were, on average, healthier than those who remained eligible for the programs. This shift was occurring to a degree that was not reflected in Elevance’s rate negotiations with the states or in its financial guidance for 2024. When the true details entered the market, the lawsuit claims that investors suffered damages. If you are a long-term stockholder of Elevance, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes. Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X. Contact Information: Bragar Eagel & Squire, P.C.Brandon Walker, Esq.Marion Passmore, Esq.(212) 355-4648investigations@bespc.comwww.bespc.com

Related News